The Food and Drug Administration is due to announce whether it will approve Flibanserin, a drug for women with HSDD or Hypoactive Sex Drive Disorder,







Female Sex Pills: FDA Decision Due [onNiITORatn]

Female Sex Pills: FDA Decision Due [onNiITORatn]

| 1h 28m 28s | Video has closed captioning.

The Food and Drug Administration is due to announce whether it will approve Flibanserin, a drug for women with HSDD or Hypoactive Sex Drive Disorder, which has been rejected twice before. Mark Kelly reports. Image: AP Subscribe to the WSJ channel here: More from the Wall Street Journal: Visit WSJ.com: Follow WSJ on Facebook: Follow WSJ on Google+: Follow WSJ on Twitter: Follow WSJ on Instagram: Follow WSJ on Pinterest: Don’t miss a WSJ video, subscribe here: More from the Wall Street Journal: Visit WSJ.com: Visit the WSJ Video Center: On Facebook: On Twitter: On Snapchat: #redspartan 3000 male enhancer #gummies after workout #penis enlargement trainer

Aired: December 26, 2024

Rating: TV-14

Buy Now:

Problems Playing Video? | Closed Captioning

Learn About Midwifery Today

Blog

Learn About Midwifery Today

Read the Modern Day Midwives Blog and learn more about our bloggers, all experienced midwives.

Read now